Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Aspen Pharmacare Holdings Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2028 | $43.46B | $40.54B - $46.42B | $8.76B | $14.825 | 1 |
| Jun 2027 | $40.90B | $38.15B - $43.69B | $8.25B | $13.524 | 2 |
| Jun 2026 | $43.57B | $40.64B - $46.54B | $8.79B | $7.812 | 2 |
| Jun 2025 | $44.90B | $41.88B - $47.96B | $9.06B | $12.336 | 3 |
| Jun 2024 | $46.11B | $43.02B - $49.26B | $9.30B | $14.131 | 2 |
| Jun 2023 | $2.13B | $2.05B - $2.17B | $429.70M | $0.794 | 1 |
| Jun 2022 | $2.34B | $2.25B - $2.38B | $471.92M | $0.909 | 1 |
| Jun 2021 | $2.59B | $2.49B - $2.64B | $522.56M | $0.847 | 2 |
| Jun 2020 | $2.26B | $2.17B - $2.30B | $455.14M | $0.786 | 1 |
| Jun 2019 | $2.64B | $2.54B - $2.69B | $532.57M | $0.909 | 1 |
| Jun 2018 | $3.01B | $2.90B - $3.07B | $607.63M | $1.135 | 2 |
| Jun 2017 | $3.16B | $3.04B - $3.22B | $637.06M | $1.094 | 1 |